blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2603233

EP2603233 - VACCINE ENGINEERING [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  14.06.2019
Database last updated on 12.07.2024
FormerExamination is in progress
Status updated on  19.05.2017
Most recent event   Tooltip14.06.2019Application deemed to be withdrawnpublished on 17.07.2019  [2019/29]
Applicant(s)For all designated states
AC Immune S.A.
EPFL-PSE Building B
1015 Lausanne / CH
[2013/25]
Inventor(s)01 / HICKMAN, David
Route de Vallaire 1
1025 Saint-Sulpice / CH
02 / LÓPEZ-DEBER, María Pilar
Rue Saint-Roch 40
1004 Lausanne / CH
03 / MUHS, Andreas
Chemin des Alouettes 12
1053 Cugy / CH
 [2013/25]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2013/25]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date11743074.412.08.2011
WO2011EP63933
Priority number, dateEP2010017261912.08.2010         Original published format: EP 10172619
[2013/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012020124
Date:16.02.2012
Language:EN
[2012/07]
Type: A1 Application with search report 
No.:EP2603233
Date:19.06.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 16.02.2012 takes the place of the publication of the European patent application.
[2013/25]
Search report(s)International search report - published on:EP16.02.2012
ClassificationIPC:A61K39/00, C07K17/06, C07K14/47
[2013/25]
CPC:
A61K39/0007 (EP,US); A61K39/385 (US); C07K16/18 (US);
A61K2039/55555 (EP,US); A61K2039/6018 (EP,US); A61K2039/64 (EP,US);
G01N2405/00 (EP,US); G01N2440/10 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/25]
TitleGerman:MANIPULATION VON IMPFSTOFFEN[2013/25]
English:VACCINE ENGINEERING[2013/25]
French:VACCIN OBTENU PAR GÉNIE GÉNÉTIQUE[2013/25]
Entry into regional phase11.03.2013National basic fee paid 
11.03.2013Designation fee(s) paid 
11.03.2013Examination fee paid 
Examination procedure11.03.2013Examination requested  [2013/25]
01.10.2013Amendment by applicant (claims and/or description)
18.05.2017Despatch of a communication from the examining division (Time limit: M04)
27.09.2017Reply to a communication from the examining division
03.08.2018Despatch of a communication from the examining division (Time limit: M06)
14.02.2019Application deemed to be withdrawn, date of legal effect  [2019/29]
13.03.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2019/29]
Divisional application(s)EP18213144.1
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.05.2017
Fees paidRenewal fee
26.08.2013Renewal fee patent year 03
22.08.2014Renewal fee patent year 04
25.08.2015Renewal fee patent year 05
26.08.2016Renewal fee patent year 06
23.08.2017Renewal fee patent year 07
20.08.2018Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US2004242845  (NICOLAU YVES CLAUDE [US], et al) [A] 1-94 * the whole document *;
 [A]WO2006066003  (DYNAVAX TECH CORP [US], et al) [A] 1-94* the whole document *;
 [XP]WO2010115843  (AC IMMUNE SA [CH], et al) [XP] 1-94 * the whole document *;
 [XI]  - MUHS ANDREAS ET AL, "Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC; US, (20070605), vol. 104, no. 23, doi:10.1073/PNAS.0703137104, ISSN 0027-8424, pages 9810 - 9815, XP002542049 [X] 1-5,26-48,51-53,57-70,79-83 * the whole document * [I] 6-25,49,50,54-56,71-78,84-94

DOI:   http://dx.doi.org/10.1073/PNAS.0703137104
 [A]  - FRISCH BENOÎT ET AL, "Synthetic peptide-based highly immunogenic liposomal constructs", METHODS IN ENZYMOLOGY; [METHODS IN ENZYMOLOGY], ACADEMIC PRESS INC, SAN DIEGO, CA, US, (20030101), vol. 373, doi:10.1016/S0076-6879(03)73004-3, ISSN 0076-6879, pages 51 - 73, XP009126641 [A] 1-94 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0076-6879(03)73004-3
Examination   - Yan Liu ET AL, "Surface Potential of Charged Liposomes Determined by Second Harmonic Generation", Langmuir, (20010401), vol. 17, no. 7, doi:10.1021/la0011634, ISSN 0743-7463, pages 2063 - 2066, XP055075634

DOI:   http://dx.doi.org/10.1021/la0011634
    - Jyothi Thundimadathil ET AL, "Aggregation and Porin-like Channel Activity of a [beta] Sheet Peptide", Biochemistry, US, (20050801), vol. 44, no. 30, doi:10.1021/bi0508643, ISSN 0006-2960, pages 10259 - 10270, XP055371593

DOI:   http://dx.doi.org/10.1021/bi0508643
    - Jyothi Thundimadathil ET AL, "Conversion of a Porin-like Peptide Channel into a Gramicidin-like Channel by Glycine to D-alanine Substitutions", Biophysical Journal, AMSTERDAM, NL, (20060201), vol. 90, no. 3, doi:10.1529/biophysj.105.072751, ISSN 0006-3495, pages 947 - 955, XP055371712

DOI:   http://dx.doi.org/10.1529/biophysj.105.072751
    - HOERNKE M ET AL, "Influence of the hydrophobic interface and transition metal ions on the conformation of amyloidogenic model peptides", BIOPHYSICAL CHEMISTRY, ELSEVIER, AMSTERDAM, NL, vol. 150, no. 1-3, ISSN 0301-4622, (20100801), pages 64 - 72, (20100301), XP027145245
    - Cyril C. Curtain ET AL, "Metal Ions, pH, and Cholesterol Regulate the Interactions of Alzheimer's Disease Amyloid-[beta] Peptide with Membrane Lipid", Journal of Biological Chemistry, US, (20030131), vol. 278, no. 5, doi:10.1074/jbc.M205455200, ISSN 0021-9258, pages 2977 - 2982, XP055495890

DOI:   http://dx.doi.org/10.1074/jbc.M205455200
    - Qing-Feng Ma ET AL, "Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR", Biopolymers, US, (20050101), vol. 79, no. 2, doi:10.1002/bip.20335, ISSN 0006-3525, pages 74 - 85, XP055495655

DOI:   http://dx.doi.org/10.1002/bip.20335
    - MCLAURIN J ET AL, "Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes", EUROPEAN JOURNAL OF BIOCHEMISTRY, WILEY-BLACKWELL PUBLISHING LTD, GB, (19970101), vol. 245, no. 2, doi:10.1111/J.1432-1033.1997.T01-2-00355.X, ISSN 0014-2956, pages 355 - 363, XP001154985

DOI:   http://dx.doi.org/10.1111/j.1432-1033.1997.t01-2-00355.x
    - Tomasz Kowalewski ET AL, "In situ atomic force microscopy study of Alzheimer's [beta]-amyloid peptide on different substrates: New insights into mechanism of [beta]-sheet formation", Proceedings of the National Academy of Sciences of the United States of America, (19990330), pages 3688 - 3693, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC22355/pdf/pq003688.pdf, XP055495644
    - David J. Gordon ET AL, "Increasing the Amphiphilicity of an Amyloidogenic Peptide Changes the [beta]-Sheet Structure in the Fibrils from Antiparallel to Parallel", BIOPHYSICAL JOURNAL, AMSTERDAM, NL, (20040101), vol. 86, no. 1, doi:10.1016/S0006-3495(04)74119-3, ISSN 0006-3495, pages 428 - 434, XP055495633

DOI:   http://dx.doi.org/10.1016/S0006-3495(04)74119-3
by applicantUS5004697
 US5112596
 US5268164
 US5506206
 US5686416
 US2002025313
 US2002038086
 US2002065259
 US2003073713
 US2003083299
 US2003129186
 US2003162695
 US2004131692
 US2004204354
 US2005089473
 US2005124533
 WO2007068411
 WO2008061795
 WO2008061796
    - FIESER, T.M. ET AL., PROC. NATL. ACAD. SCI. U. S. A., (1987), vol. 84, page 8568
    - LU, S.M., HODGES, R.S., J. BIOL. CHEM., (2002), vol. 277, page 23515
    - O'NUALLAIN, B., WETZEL, R., PROC. NATL. ACAD. SCI. U. S. A., (2002), vol. 99, page 1485
    - SCHMECHEL, A. ET AL., "Alzheimer beta-amyloid homodimers facilitate A beta fibrillization and the generation of conformational antibodies", J. BIOL. CHEM., (2003), vol. 278, doi:doi:10.1074/JBC.M303547200, page 35317, XP002500246

DOI:   http://dx.doi.org/10.1074/JBC.M303547200
    - ALVING, INFECT. IMMUN., (1992), vol. 60, pages 2438 - 2444
    - WAGNER ET AL., JOURNAL OF LIPOSOME RESEARCH, (2002), vol. 12, no. 3, pages 259 - 270
    - PAPANASTASSIOU ET AL., GENE THERAPY, (2002), vol. 9, pages 398 - 406
    - GILL ET AL., NATURE MED., (2003), vol. 9, pages 589 - 595
    - NEUWELT, E. A., Implication of the Blood-Brain Barrier and its Manipulation, PLENUM PRESS, (1989), vol. 1, 2
    - KHAW, B. A. ET AL., J. NUCL. MED., (1982), vol. 23, pages 1011 - 1019
    - ROUSSEAUX ET AL., Methods Enzymology, ACADEMIC PRESS, (1986), vol. 121, pages 663 - 69
    - QUEEN ET AL., PROC. NATL ACAD SCI USA, (1989), vol. 86, pages 10029 - 10032
    - HODGSON ET AL., BIO/TECHNOLOY, (1991), vol. 9, page 421
    - MUHS, A. ET AL., PROC. NATL. ACAD. SCI. U. S. A., (2007), vol. 104, page 9810
    - ALVING ET AL., INFECT. IMMUN., (1992), vol. 60, pages 2438 - 2444
    - FIESER, T.M. ET AL., "Influence of protein flexibility and peptide conformation on reactivity of monoclonal anti-peptide antibodies with a protein alpha-helix", PROC. NATL. ACAD. SCI. U. S. A., (1987), vol. 84, page 8568
    - "Protein Identification and Analysis Tools on the ExPASy Server", GASTEIGER E., HOOGLAND C., GATTIKER A., DUVAUD S., WILKINS M.R., APPEL R.D., BAIROCH A, The Proteomics Protocols Handbook, HUMANA PRESS, (2005), pages 571 - 607
    - HODGSON, BIOITECHNOLOY, (1991), vol. 9, page 421
    - LU, S.M., HODGES, R.S., "A de novo designed template for generating conformation-specific antibodies that recognize alpha-helices in proteins", J. BIOL. CHEM., (2002), vol. 277, page 23515
    - MUHS, A. ET AL., "Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice", PROC. NATL. ACAD. SCI. U. S. A., (2007), vol. 104, doi:doi:10.1073/PNAS.0703137104, page 9810, XP002542049

DOI:   http://dx.doi.org/10.1073/PNAS.0703137104
    - O'NUALLAIN, B., WETZEL, R., "Conformational Abs recognizing a generic amyloid fibril epitope", PROC. NATL. ACAD. SCI. U. S. A., (2002), vol. 99, doi:doi:10.1073/pnas.022662599, page 1485, XP002211263

DOI:   http://dx.doi.org/10.1073/pnas.022662599
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.